Oral Fluvoxamine Plus Budesonide Cuts Severe Disease in COVID-19

TUESDAY, April 18, 2023 -- For high-risk outpatients with COVID-19, treatment with oral fluvoxamine plus budesonide reduces the incidence of severe disease needing advanced care, according to a study published online April 18 in the Annals of...